GeneDx Net Receivables from 2010 to 2026
| WGSWW Stock | 0.02 0 10.64% |
Net Receivables | First Reported 2020-12-31 | Previous Quarter 48 M | Current Value 60.9 M | Quarterly Volatility 9.5 M |
Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 28.4 M or Interest Expense of 2.7 M, as well as many indicators such as Price To Sales Ratio of 5.59, Dividend Yield of 0.0 or PTB Ratio of 9.21. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
GeneDx | Net Receivables | Build AI portfolio with GeneDx Stock |
The evolution of Net Receivables for GeneDx Holdings Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how GeneDx Holdings compares to historical norms and industry peers.
Latest GeneDx Holdings' Net Receivables Growth Pattern
Below is the plot of the Net Receivables of GeneDx Holdings Corp over the last few years. It is GeneDx Holdings' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
GeneDx Net Receivables Regression Statistics
| Arithmetic Mean | 33,957,448 | |
| Geometric Mean | 33,723,218 | |
| Coefficient Of Variation | 12.53 | |
| Mean Deviation | 3,106,449 | |
| Median | 32,333,000 | |
| Standard Deviation | 4,254,465 | |
| Sample Variance | 18.1T | |
| Range | 16.8M | |
| R-Value | 0.53 | |
| Mean Square Error | 13.8T | |
| R-Squared | 0.28 | |
| Significance | 0.03 | |
| Slope | 447,935 | |
| Total Sum of Squares | 289.6T |
GeneDx Net Receivables History
About GeneDx Holdings Financial Statements
GeneDx Holdings investors use historical fundamental indicators, such as GeneDx Holdings' Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeneDx Holdings. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 43.3 M | 38 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.